These previous results also provide insights into the pathogenic mechanism that underlies loss of eCB in PTSD, showing that both overexpressing CB1 and treatment with FAAH inhibitors can protect against PTSD. This evidence concerns the gene FAAH and post-traumatic stress disorder.